Cost–effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial

AIMS: To conduct a health economic evaluation of ticagrelor in patients with type 2 diabetes and coronary artery disease (CAD) from a multinational payer perspective. Cost–effectiveness and cost–utility of ticagrelor were evaluated in the overall effect of Ticagrelor on Health Outcomes in Diabetes M...

Descripción completa

Detalles Bibliográficos
Autores principales: Steg, Philippe Gabriel, Bhatt, Deepak L, James, Stefan K, Darlington, Oliver, Hoskin, Louise, Simon, Tabassome, Fox, Kim M, Leiter, Lawrence A, Mehta, Shamir R, Harrington, Robert A, Himmelmann, Anders, Ridderstråle, Wilhelm, Andersson, Marielle, Bueno, Héctor, De Luca, Leonardo, Tank, Amarjeet, Mellström, Carl, McEwan, Phil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716869/
https://www.ncbi.nlm.nih.gov/pubmed/35488865
http://dx.doi.org/10.1093/ehjcvp/pvac032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716869/
https://www.ncbi.nlm.nih.gov/pubmed/35488865
http://dx.doi.org/10.1093/ehjcvp/pvac032

Ejemplares similares